Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were initially approved for the treatment of type 2 diabetes (T2D) and obesity, have cardiovascular benefits that extend beyond glycaemic control
The KwikPens have a dose knob, but Lilly labels them as delivering four fixed doses and does not provide a validated click-to-milligram conversion for fractional dosing
Substantial weight lossa primary effect of these medicationstypically leads to decreased blood pressure, which is generally beneficial for patients with hypertension
Cancers Associated with Overweight and Obesity Make up 40% of Cancers Diagnosed in the United States
At Lush RX, were here to help you every step of the way
Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A (2014) Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin